237 related articles for article (PubMed ID: 10772310)
1. Resistance to botulinum toxin injections for spasmodic dysphonia.
Smith ME; Ford CN
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):533-5. PubMed ID: 10772310
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin for the treatment of spasmodic dysphonia.
Gibbs SR; Blitzer A
Otolaryngol Clin North Am; 2000 Aug; 33(4):879-94. PubMed ID: 10918666
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin for spasmodic dysphonia.
Rodriquez AA
Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):767-79. PubMed ID: 14580036
[TBL] [Abstract][Full Text] [Related]
4. A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia.
Meleca RJ; Hogikyan ND; Bastian RW
Otolaryngol Head Neck Surg; 1997 Nov; 117(5):487-92. PubMed ID: 9374172
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of spasmodic dysphonia with botulinum toxin].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
[TBL] [Abstract][Full Text] [Related]
6. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
Stong BC; DelGaudio JM; Hapner ER; Johns MM
Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies.
Whurr R; Nye C; Lorch M
Int J Lang Commun Disord; 1998; 33 Suppl():327-9. PubMed ID: 10343714
[TBL] [Abstract][Full Text] [Related]
8. The impact of long-term botulinum toxin injections on symptom severity in patients with spasmodic dysphonia.
Damrose JF; Goldman SN; Groessl EJ; Orloff LA
J Voice; 2004 Sep; 18(3):415-22. PubMed ID: 15331116
[TBL] [Abstract][Full Text] [Related]
9. Contemporary management of spasmodic dysphonia.
Sulica L
Curr Opin Otolaryngol Head Neck Surg; 2004 Dec; 12(6):543-8. PubMed ID: 15548915
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia.
Benninger MS; Gardner G; Grywalski C
Arch Otolaryngol Head Neck Surg; 2001 Sep; 127(9):1083-5. PubMed ID: 11556856
[TBL] [Abstract][Full Text] [Related]
12. [Results of using botulism toxin in the treatment of spasmodic dysphonia].
Larrosa F; Idígora A; Aguilar F; Riera L; Martí MJ; Valls J
Acta Otorrinolaringol Esp; 2002 Jan; 53(1):27-31. PubMed ID: 11998515
[TBL] [Abstract][Full Text] [Related]
13. Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia.
Adams SG; Durkin LC; Irish JC; Wong DL; Hunt EJ
Laryngoscope; 1996 Mar; 106(3 Pt 1):296-300. PubMed ID: 8614192
[TBL] [Abstract][Full Text] [Related]
14. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin.
Brin MF; Blitzer A; Stewart C
Adv Neurol; 1998; 78():237-52. PubMed ID: 9750921
[No Abstract] [Full Text] [Related]
15. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review.
Watts C; Nye C; Whurr R
Clin Rehabil; 2006 Feb; 20(2):112-22. PubMed ID: 16541931
[TBL] [Abstract][Full Text] [Related]
16. Laryngeal electromyography in movement disorders: preliminary data.
Kimaid PA; Quagliato EM; Crespo AN; Wolf A; Viana MA; Resende LA
Arq Neuropsiquiatr; 2004 Sep; 62(3A):741-4. PubMed ID: 15334243
[TBL] [Abstract][Full Text] [Related]
17. Treatment of ventricular dysphonia with botulinum toxin.
Kendall KA; Leonard RJ
Laryngoscope; 1997 Jul; 107(7):948-53. PubMed ID: 9217137
[TBL] [Abstract][Full Text] [Related]
18. Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A.
Guntinas-Lichius O
Laryngoscope; 2003 Apr; 113(4):743-5. PubMed ID: 12671439
[No Abstract] [Full Text] [Related]
19. Botulinum toxin type B for treatment of spasmodic dysphonia: a case report.
Sataloff RT; Heman-Ackah YD; Simpson LL; Park JB; Zwislewski A; Sokolow C; Mandel S
J Voice; 2002 Sep; 16(3):422-4. PubMed ID: 12395995
[TBL] [Abstract][Full Text] [Related]
20. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].
Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED
Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
